General MedicationsORALGeneric
OXAZEPAM
OXAZEPAM
Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview OXAZEPAM is listed in Drugs@FDA under application 071508 (ANDA).
Marketing status: Discontinued Active ingredient OXAZEPAM Form and strength TABLET;ORAL - 15MG Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview OXAZEPAM is listed in Drugs@FDA under application 071508 (ANDA). Marketing status: Discontinued Active ingredient OXAZEPAM Form and strength TABLET;ORAL - 15MG Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.